程 躍,周 晉,侯艷梅,郭玉琨
·論著·
·中醫(yī)·中西醫(yī)結(jié)合研究·
基于傾向性匹配法評(píng)價(jià)苦參湯熏洗結(jié)合八髎穴盒灸治療高位復(fù)雜性肛瘺患者術(shù)后并發(fā)癥的臨床療效研究
程 躍*,周 晉,侯艷梅,郭玉琨
目的 評(píng)價(jià)苦參湯熏洗結(jié)合八髎穴盒灸治療高位復(fù)雜性肛瘺患者術(shù)后并發(fā)癥的臨床療效。方法 回顧性選取2010年9月—2015年9月成都中醫(yī)藥大學(xué)附屬醫(yī)院肛腸科住院部收治的符合納入標(biāo)準(zhǔn)的高位復(fù)雜性肛瘺患者873例,采用SPSS 20.0的傾向性匹配法成功匹配苦參湯熏洗結(jié)合八髎穴盒灸組128例(A組)、苦參湯熏洗組128例(B組)和八髎穴盒灸組128例(C組)。A組給予苦參湯熏洗結(jié)合八髎穴盒灸治療,B組給予苦參湯熏洗治療,C組給予八髎穴盒灸治療;3組患者均治療14 d。術(shù)后14 d時(shí)評(píng)價(jià)患者臨床療效,術(shù)后第1、7、14天時(shí)采用疼痛數(shù)字評(píng)分法(NRS)評(píng)價(jià)術(shù)后疼痛程度,術(shù)后第1和3天時(shí)觀察患者尿潴留發(fā)生情況。結(jié)果 術(shù)后第14天,3組患者臨床療效比較,差異有統(tǒng)計(jì)學(xué)意義(P<0.05);A組患者的臨床療效優(yōu)于B組和C組(P<0.05);B組和C組臨床療效比較,差異無統(tǒng)計(jì)學(xué)意義(P>0.05)。治療方法與治療時(shí)間在NRS評(píng)分上存在交互作用(P<0.05),治療時(shí)間在NRS評(píng)分上主效應(yīng)不顯著(P>0.05),治療方法在NRS評(píng)分上主效應(yīng)顯著(P<0.05)。術(shù)后第7天,A組患者NRS評(píng)分低于B組和C組(P<0.05),B組患者NRS評(píng)分低于C組(P<0.05)。術(shù)后第14天,A組和B組患者NRS評(píng)分低于C組(P<0.05),A組和B組患者NRS評(píng)分比較差異無統(tǒng)計(jì)學(xué)意義(P>0.05)。術(shù)后第1天,3組患者尿潴留發(fā)生率比較,差異無統(tǒng)計(jì)學(xué)意義(P>0.05)。術(shù)后第3天,3組患者尿潴留發(fā)生率比較,差異有統(tǒng)計(jì)學(xué)意義(P<0.05)。結(jié)論 苦參湯熏洗結(jié)合八髎穴盒灸能有效減輕高位復(fù)雜性肛瘺患者術(shù)后疼痛及降低尿潴留發(fā)生率。
直腸瘺;苦參;穴,八髎;灸法;治療結(jié)果
程躍,周晉,侯艷梅,等.基于傾向性匹配法評(píng)價(jià)苦參湯熏洗結(jié)合八髎穴盒灸治療高位復(fù)雜性肛瘺患者術(shù)后并發(fā)癥的臨床療效研究[J].中國(guó)全科醫(yī)學(xué),2017,20(3):342-346.[www.chinagp.net]
CHENG Y,ZHOU J,HOU Y M,et al.Evaluation of the clinical effect of sophora flavescens decoction fumigation combined with box moxibustion at Baliao acupoint on treating postoperative complications in patients with high complicated anal fistula on the basis of propensity score matching[J].Chinese General Practice,2017,20(3):342-346.
高位復(fù)雜性肛瘺的瘺管位置高、病程長(zhǎng),是肛腸科公認(rèn)的疑難病。手術(shù)治療高位復(fù)雜性肛瘺要求清創(chuàng)徹底、引流通暢,該要求促使高位復(fù)雜性肛瘺患者術(shù)后創(chuàng)面較其他肛腸疾病大,因此,高位復(fù)雜性肛瘺術(shù)后具有創(chuàng)面愈合慢、疼痛程度重、尿便障礙發(fā)生率高等特點(diǎn)[1-3]。研究和改進(jìn)防治高位復(fù)發(fā)性肛瘺術(shù)后并發(fā)癥的臨床措施,是目前肛腸科臨床研究的熱點(diǎn)。肛瘺在中醫(yī)學(xué)中多辨證為“濕熱下注”,因此苦參湯常用于肛瘺的臨床治療[4-6],筆者總結(jié)臨床經(jīng)驗(yàn)和前期研究發(fā)現(xiàn),高位復(fù)雜性肛瘺患者術(shù)后除了有濕熱下注外,還伴有手術(shù)損傷帶來的氣虛血瘀(術(shù)后疼痛、創(chuàng)面難愈和尿潴留)[7-8];使用苦參湯坐浴熏洗結(jié)合八髎穴盒灸能有效減少術(shù)后并發(fā)癥,然而,尚無循證醫(yī)學(xué)證據(jù)證明該療法的有效性。本研究擬在傾向性匹配法(propensity score matching,PSM)的基礎(chǔ)上評(píng)價(jià)苦參湯熏洗結(jié)合八髎穴盒灸治療高位復(fù)雜性肛瘺患者術(shù)后并發(fā)癥的臨床療效,現(xiàn)報(bào)道如下。
1.1 診斷標(biāo)準(zhǔn) 高位復(fù)雜性肛瘺患者的診斷參考中華中醫(yī)藥學(xué)會(huì)肛腸分會(huì)、中華醫(yī)學(xué)會(huì)外科學(xué)分會(huì)結(jié)直腸肛門外科學(xué)組、中國(guó)中西醫(yī)結(jié)合學(xué)會(huì)大腸肛門病專業(yè)委員會(huì)制定的《肛瘺臨床診治指南(2006版)》[9]。
1.2 病例納入、排除標(biāo)準(zhǔn) (1)納入標(biāo)準(zhǔn):符合診斷標(biāo)準(zhǔn);年齡18~75歲;查體和經(jīng)直腸腔內(nèi)超聲檢查無肛門形態(tài)和功能異常;采用苦參湯熏洗、八髎穴盒灸或苦參湯熏洗結(jié)合八髎穴盒灸治療高位復(fù)雜性肛瘺患者術(shù)后并發(fā)癥;高位復(fù)雜性肛瘺患者術(shù)后疼痛數(shù)字評(píng)分法(numeric rating scale,NRS)評(píng)分、術(shù)后切口和術(shù)后尿潴留評(píng)價(jià)資料完整。(2)排除標(biāo)準(zhǔn):合并炎性腸病或由炎性腸病引起的高位復(fù)雜性肛瘺;診斷為腸道腫瘤;因血液系統(tǒng)疾病或結(jié)核引發(fā)的高位復(fù)雜性肛瘺;有嚴(yán)重的心血管系統(tǒng)疾病或肝腎功能衰竭。
1.3 一般資料 從成都中醫(yī)藥大學(xué)附屬醫(yī)院肛腸科電子病例數(shù)據(jù)庫(kù)及以往隨機(jī)對(duì)照試驗(yàn)研究數(shù)據(jù)庫(kù)中,選取2010年9月—2015年9月于成都中醫(yī)藥大學(xué)附屬醫(yī)院肛腸科住院部就診的高位復(fù)雜性肛瘺患者873例,分為苦參湯熏洗結(jié)合八髎穴盒灸組(A組)、苦參湯熏洗組(B組)和八髎穴盒灸組(C組)。采用SPSS 20.0統(tǒng)計(jì)軟件中的PSM對(duì)患者年齡、性別、病程和手術(shù)方式進(jìn)行匹配。采用1∶1最鄰近匹配算法,卡鉗值取0.15,以苦參湯熏洗結(jié)合八髎穴盒灸組作為基準(zhǔn)組進(jìn)行匹配,匹配成功后每組128例。3組患者年齡、性別、病程、手術(shù)方式比較,差異無統(tǒng)計(jì)學(xué)意義(P>0.05,見表1)。
表1 3組患者匹配前后基線資料比較
注:a為F值,b為χ2值,余檢驗(yàn)統(tǒng)計(jì)量值為H值;A組=苦參湯熏洗結(jié)合八髎穴盒灸組,B組=苦參湯熏洗組,C組=八髎穴盒灸組
1.4 方法 術(shù)后當(dāng)日A組患者給予苦參湯熏洗結(jié)合八髎穴盒灸治療,B組給予苦參湯熏洗治療,C組給予八髎穴盒灸治療。具體措施如下:(1)手術(shù)治療。①切開掛線法:常規(guī)手術(shù)麻醉后先探查肛瘺的內(nèi)外口位置,確定內(nèi)口后,從外口向內(nèi)口將瘺管切開并掛線治療;②多切口浮線引流:腰俞穴麻醉后,在膿腫隆起最明顯處做放射狀切口排膿,并視膿腫范圍在距離肛緣2 cm外做1~4個(gè)放射狀輔助引流切口。(2)苦參湯熏洗。自擬苦參湯處方如下:苦參、蛇床子、白芷、(野)菊花、黃柏、地膚子、菖蒲、金銀花各15 g。將上述藥物置于砂鍋內(nèi),加入2 L清水浸泡30 min,之后用武火熬制20 min濾除藥汁備用。重新加入2 L清水重復(fù)上述熬藥取汁,并將兩次藥汁混合后放入冰片。每日便后或者睡前熏洗1 次,熏5~10 min清洗肛周局部。(3)八髎穴盒灸。患者術(shù)后接受盒灸八髎穴治療,1 次/d,具體操作如下:患者取俯臥位,醫(yī)者選取患者雙側(cè)上髎、次髎、中髎和下髎共8 穴,使用艾條(2 cm長(zhǎng),成都濱江廠生產(chǎn))3~5 段點(diǎn)燃后投入艾灸盒,將艾灸盒放置到上述8 穴施灸,以患者感覺溫?zé)釤o灼燙感為宜。3組均治療14 d。
1.5 觀察指標(biāo)及判定標(biāo)準(zhǔn) (1)臨床療效判定標(biāo)準(zhǔn)[10]:術(shù)后14 d時(shí)評(píng)價(jià)患者臨床療效。痊愈:創(chuàng)面愈合,無流膿、肛門墜脹、疼痛及瘙癢,無尿潴留;顯效:創(chuàng)面愈合,無流膿及肛門墜脹,疼痛及瘙癢明顯改善,無尿潴留;未愈:創(chuàng)面未愈合,流膿、墜脹、疼痛或瘙癢未見明顯改善。(2)術(shù)后NRS評(píng)分[8]:NRS評(píng)分將疼痛程度分為11個(gè)級(jí)別,0分為完全無痛,10分為最痛。囑患者根據(jù)自身NRS感受,于術(shù)后第1、7、14天評(píng)價(jià)MRS得分。(3)術(shù)后尿潴留發(fā)生率:尿潴留判斷標(biāo)準(zhǔn)為患者自覺有尿意且嘗試排尿后未能成功,或經(jīng)新斯的明5 mg足三里穴注射,或需要留置尿管方能排尿。于術(shù)后第1、3天時(shí)比較3組患者尿潴留發(fā)生率。
2.1 臨床療效 術(shù)后第14天,3組患者臨床療效比較,差異有統(tǒng)計(jì)學(xué)意義(H=6.249,P<0.05,見表2)。A組患者的臨床療效優(yōu)于B組和C組,差異有統(tǒng)計(jì)學(xué)意義(χ2值分別為7.115、6.609,P<0.05);B組和C組臨床療效比較,差異無統(tǒng)計(jì)學(xué)意義(χ2=0.021,P=0.982)。
2.2 術(shù)后疼痛程度 治療方法與治療時(shí)間在NRS評(píng)分上存在交互作用(P<0.05),治療時(shí)間在NRS評(píng)分上主效應(yīng)不顯著(P>0.05),治療方法在NRS評(píng)分上主效應(yīng)顯著(P<0.05)。術(shù)后第7天,A組患者NRS評(píng)分低于B組和C組,差異有統(tǒng)計(jì)學(xué)意義(P<0.05);術(shù)后第7天B組患者NRS評(píng)分低于C組,差異有統(tǒng)計(jì)學(xué)意義(P<0.05)。術(shù)后第14天,A組和B組患者NRS評(píng)分低于C組,差異有統(tǒng)計(jì)學(xué)意義(P<0.05);術(shù)后第14天,A組和B組患者NRS評(píng)分比較,差異無統(tǒng)計(jì)學(xué)意義(P>0.05,見表3)。
表2 3組患者臨床療效比較 〔n(%)〕
Table3ComparisonofNRSscoreofpatientsinthethreegroupsafteroperation
組別例數(shù)術(shù)后第1天術(shù)后第7天術(shù)后第14天A組12879±1730±09a16±05aB組12872±1939±06ab17±08aC組12874±1548±08abc28±06abcF值F交互=5882,F(xiàn)時(shí)間=0991,F(xiàn)組間=9852P值P交互=0022,P時(shí)間=0328,P組間=0002
注:與組內(nèi)術(shù)后第1天比較,aP<0.05;與同時(shí)間點(diǎn)A組比較,bP<0.05;與同時(shí)間點(diǎn)B組比較,cP<0.05
2.3 尿潴留發(fā)生率 術(shù)后第1天,A組患者發(fā)生尿潴留31例(24.2%),B組29例(22.6%),C組33例(25.8%),3組患者尿潴留發(fā)生率比較,差異無統(tǒng)計(jì)學(xué)意義(χ2=0.341,P=0.843)。術(shù)后第3天,經(jīng)治療仍需要新斯的明或者留置尿管處理的患者A組有1例(0.8%),B組有12例(9.4%),C組有3例(2.3%),3組患者尿潴留發(fā)生率比較,差異有統(tǒng)計(jì)學(xué)意義(χ2=13.435,P<0.05)。
我國(guó)傳統(tǒng)醫(yī)學(xué)認(rèn)為肛瘺的發(fā)生與濕熱、痰火及氣血不足有關(guān)。《河間六書》記載:“蓋以風(fēng)熱不散,谷氣流溢,傳于下部,故令肛門腫滿,結(jié)如梅李核,甚者乃變?yōu)榀浺病?。清代《外科醫(yī)案匯編》評(píng)述:“肛漏者,皆屬肝脾腎三陰氣血不足……”?!锻饪普凇分袆t記載“虛勞久咳,痰火結(jié)腫肛門如栗者,破必成瘺。”上述記載均說明熱、痰、虛是肛瘺的主要致病因素。因此,采用苦參湯作為主方熏洗肛門局部是目前肛瘺術(shù)后治療的重要手段,可起到去濕熱、化腐生肌的功效。近年來多項(xiàng)臨床試驗(yàn)研究表明,苦參湯加減能有效促進(jìn)肛瘺患者術(shù)后創(chuàng)面愈合,降低創(chuàng)面感染發(fā)生率[11-12]。然而,目前絕大多數(shù)研究均著重于解決濕熱下注的問題,對(duì)于患者因氣血不足導(dǎo)致的肛瘺或者術(shù)后多虛多瘀的問題關(guān)注不夠。臨床研究表明,肛腸術(shù)后患者均有一定程度的氣血不足[13];中醫(yī)學(xué)理論中氣虛也是產(chǎn)生血瘀的重要因素,血瘀致使患者術(shù)后疼痛時(shí)間延長(zhǎng),進(jìn)而引發(fā)術(shù)后尿潴留和傷口愈合時(shí)間長(zhǎng)的問題。然而,這些臨床問題尚未引起足夠重視,關(guān)于術(shù)后氣虛血瘀干預(yù)措施的臨床效果評(píng)價(jià)研究極少。根據(jù)筆者的臨床經(jīng)驗(yàn)和前期研究結(jié)果,在苦參湯肛周局部熏洗的基礎(chǔ)上結(jié)合八髎穴盒灸的方法能有效減輕肛瘺患者術(shù)后疼痛、促進(jìn)傷口愈合[7-8]。因此,筆者針對(duì)以往研究對(duì)氣虛血瘀導(dǎo)致疼痛程度重、尿潴留發(fā)生率高等問題關(guān)注不足的特點(diǎn)[14],通過PSM探討苦參湯熏洗結(jié)合八髎穴盒灸治療高位復(fù)雜性肛瘺患者術(shù)后并發(fā)癥的臨床療效。
3.1 臨床療效 苦參湯熏洗肛周局部是臨床防治肛腸疾病術(shù)后并發(fā)癥的重要方法。高位復(fù)雜性肛瘺患者2周痊愈率為30%~60%[15]。本研究結(jié)果顯示,苦參湯熏洗結(jié)合八髎穴盒灸能有效緩解高位復(fù)雜性肛瘺患者術(shù)后疼痛和尿潴留問題,術(shù)后第14天的痊愈率高達(dá)64.8%,而單用苦參湯熏洗為50.8%,單用八髎穴盒灸為52.3%;提示苦參湯熏洗結(jié)合八髎穴盒灸能起到協(xié)同增效的作用,兩者結(jié)合的方法比以往研究的痊愈率高[16]。相比以往研究,本研究的干預(yù)措施增加了八髎穴盒灸的方法[16]。有研究表明,盒灸能減輕創(chuàng)傷局部的炎性反應(yīng),促進(jìn)傷口愈合[17]。在中醫(yī)外治方法中,盒灸作為補(bǔ)氣活血的主要方法,在臨床中運(yùn)用較廣,能有效緩解患者氣虛血瘀的狀態(tài)。為此,筆者認(rèn)為八髎穴盒灸能在苦參湯熏洗減輕手術(shù)創(chuàng)面局部炎性水腫的基礎(chǔ)上,進(jìn)一步減輕創(chuàng)面炎性反應(yīng)及水腫,從而提高總體療效;但這一假設(shè)還需要進(jìn)一步的基礎(chǔ)研究證實(shí)。
3.2 術(shù)后疼痛和尿潴留 術(shù)后疼痛和尿潴留是高位復(fù)雜性肛瘺最為常見的術(shù)后并發(fā)癥。研究表明,術(shù)后疼痛程度與尿潴留發(fā)生率有關(guān)[18]。國(guó)外一項(xiàng)回顧性研究表明,術(shù)后3 d尿潴留發(fā)生率高達(dá)7.88%[15]。本研究結(jié)果表明,苦參湯熏洗和八髎穴盒灸合用能顯著降低術(shù)后3 d尿潴留發(fā)生率,從術(shù)后第1天的24.2%降低至術(shù)后第3天的0.8%。此外,本研究發(fā)現(xiàn),術(shù)后第7天和第14天時(shí),A組和B組患者的NRS評(píng)分低于C組,表明苦參湯熏洗在減輕術(shù)后疼痛方面要優(yōu)于八髎穴盒灸;而術(shù)后第3天,A組和C組患者尿潴留發(fā)生率低于B組,表明在降低尿潴留發(fā)生率方面,八髎穴盒灸要優(yōu)于苦參湯熏洗。兩種措施結(jié)合效果較好的原因在于綜合了苦參湯熏洗促進(jìn)傷口愈合、減輕炎性刺激的優(yōu)勢(shì)和八髎穴盒灸補(bǔ)氣活血、興奮副交感神經(jīng)促進(jìn)膀胱收縮的特點(diǎn)。八髎穴是上髎、次髎、中髎和下髎的統(tǒng)稱,因其左右側(cè)各有一穴,共為8穴,臨床上常用于下腰背部疼痛、婦科疾病和肛腸疾病的治療。有研究表明,電針八髎穴能有效緩解痔瘡術(shù)后疼痛[19]。筆者臨床研究發(fā)現(xiàn),電針八髎穴的難點(diǎn)在于穴位的定位,由于上髎、次髎、中髎和下髎分別對(duì)應(yīng)于第一、二、三和四骶后孔,準(zhǔn)確定位相對(duì)較難,容易出現(xiàn)取穴不準(zhǔn)的問題。為此,本研究將針刺改為盒灸,既能通過八髎穴發(fā)揮其活血散瘀的功效,又能通過艾灸的溫補(bǔ)作用起到補(bǔ)氣活血的功效。
本研究的創(chuàng)新點(diǎn)在于使用了真實(shí)世界臨床研究中的PSM以及NRS評(píng)分客觀評(píng)定疼痛程度。臨床隨機(jī)對(duì)照試驗(yàn)是目前公認(rèn)的驗(yàn)證臨床療效的金標(biāo)準(zhǔn),但隨機(jī)對(duì)照試驗(yàn)對(duì)治療措施的嚴(yán)格限制導(dǎo)致其外推性較差[20],即臨床實(shí)際應(yīng)用時(shí)該治療措施的療效與研究結(jié)果有較大偏差或者措施無法應(yīng)用于臨床,因此,真實(shí)世界臨床研究方法逐漸應(yīng)用于中醫(yī)藥研究領(lǐng)域[21]。PSM是真實(shí)世界臨床研究的重要研究方法之一[22],通過PSM能夠排除試驗(yàn)結(jié)果的混雜因素,達(dá)到研究結(jié)果和隨機(jī)對(duì)照試驗(yàn)結(jié)果相近的目的(類隨機(jī)對(duì)照試驗(yàn))。本研究發(fā)現(xiàn),通過PSM,能夠剔除影響試驗(yàn)結(jié)果的人群,使不均衡的基線資料趨于一致。使用NRS評(píng)分評(píng)價(jià)患者的術(shù)后疼痛程度是本研究的一大特點(diǎn)。以往研究多采用視覺模擬評(píng)分法(visual analogue scale,VAS)評(píng)分進(jìn)行術(shù)后疼痛程度評(píng)價(jià)[16],而規(guī)范的VAS評(píng)價(jià)應(yīng)為:在無刻度的10 cm長(zhǎng)橫線上通過視覺模擬疼痛程度在橫線之間做標(biāo)記,用尺子測(cè)量從0點(diǎn)到標(biāo)記之間的距離來得出VAS評(píng)分。筆者前期研究發(fā)現(xiàn),國(guó)內(nèi)部分人群對(duì)VAS評(píng)分標(biāo)準(zhǔn)理解有困難,從而導(dǎo)致疼痛程度的評(píng)估出現(xiàn)偏差[14]。本研究不足之處在于隨訪時(shí)間較短??紤]到高位復(fù)雜性肛瘺在2年內(nèi)的復(fù)發(fā)率高達(dá)7.58%[12],未來研究將增加術(shù)后2年的隨訪數(shù)據(jù)。
總之,本研究通過類臨床隨機(jī)對(duì)照試驗(yàn)證實(shí)了苦參湯坐浴熏洗結(jié)合八髎穴盒灸能有效解決高位復(fù)雜性肛瘺術(shù)后疼痛、創(chuàng)面愈合慢和尿潴留的問題,該方法簡(jiǎn)便、價(jià)廉值得臨床推廣應(yīng)用。
作者貢獻(xiàn):程躍進(jìn)行試驗(yàn)設(shè)計(jì)與實(shí)施、資料收集整理、撰寫論文、成文并對(duì)文章負(fù)責(zé);周晉和侯艷梅進(jìn)行試驗(yàn)實(shí)施、評(píng)估、資料收集,郭玉琨進(jìn)行質(zhì)量控制及審校。
本文無利益沖突。
[1]BARTOLO D C.Discussion on anal fistulas[J].Dis Colon Rectum,2014,57(8):1022-1024.
[2]KJAER M D,KJELDSEN J,QVIST N.Poor outcomes of complicated pouch-related fistulas after ileal pouch-anal anastomosis surgery[J].Scand J Surg,2016,105(3):163-167.
[3]O′RIORDAN J M,DATTA I,JOHNSTON C,et al.A systematic review of the anal fistula plug for patients with Crohn′s and non-Crohn′s related fistula-in-ano[J].Dis Colon Rectum,2012,55(3):351-358.
[4]宗振,陳雙.高位復(fù)雜性肛瘺的治療進(jìn)展[J].嶺南現(xiàn)代臨床外科,2012,12(2):155-158. ZONG Z,CHEN S.Progress in the treaetment of high complex anal fistula [J].Lingnan Modern Clinics in Surgery,2012,55(3):351-358.
[5]WANG D M,LUO Y,WANG M Y,et al.Clinical application of Chinese decoction pieces in general hospital:problems and countermeasures[J].China Pharmacy,2009,33(10):38-39.
[6]DEYING W,JIAN K.Clinic observation of compound Kushen Decoction Fumigation combined with millimeter wave local irradiation in the treatment of postoperative edema after hemorrhoids surgery[J].Journal of Colorectal & Anal Surgery,2011,10(1):10-11.
[7]程躍.術(shù)后擴(kuò)創(chuàng)對(duì)促進(jìn)高位肛瘺切開引流術(shù)后切口愈合的研究[J].檢驗(yàn)醫(yī)學(xué)與臨床,2015,12(19):2845-2846,2849. CHENG Y.Postoperative debridement for improving the wound healing after surgery for high complex anal fistula[J].Laboratory Medicine and Clinic,2015,12(19):2845-2846,2849.
[8]程躍,周晉.溫盒灸療法預(yù)防肛腸術(shù)后尿潴留臨床研究[J].亞太傳統(tǒng)醫(yī)藥,2013,9(11):71-72. CHENG Y,ZHOU J.A clinical study of box moxibustion for preventing urine retention after colorectal surgery[J]. Asia-Pacific Traditional Medicine,2013,9(11):71-72.
[9]易秉強(qiáng),王振軍,楊新慶.解讀肛周膿腫和肛瘺治療指南[J].中國(guó)臨床醫(yī)生,2008,36(8):77-79. YI B Q,WANG Z J,YANG Q X.Understandings of guidelines for perianal abscess and anal fistula[J].Chinese Journal for Clinicians,2008,36(8):77-79.
[10]ERIKSSON K,WIKSTR?M L,?RESTEDT K,et al.Numeric rating scale:patients′ perceptions of its use in postoperative pain assessments[J].Appl Nurs Res,2014,27(1):41-46.
[11]王美琴.苦參湯沖洗高位單純性肛瘺術(shù)后創(chuàng)腔療效觀察[J].亞太傳統(tǒng)醫(yī)藥,2014,10(11):99-100. WANG M Q.Clinical efficacy of Kushen decoction for postoperative high simple anal fistula[J].Asia-Pacific Traditional Medicine,2014,10(11):99-100.
[12]陳植,李忠卓.肛瘺術(shù)后主流中醫(yī)外治法機(jī)制研究[J].中國(guó)醫(yī)藥臨床雜志,2016(1):149-150. CHEN Z,LI Z Z.Review the mechanism of the main external therapy of traditional Chinese medicine after operation of a nal fistula[J].Chinese Journal of Clinical Medicine,2016(1):149-150.
[13]彭云花,楊巍.痔痛安方改善混合痔術(shù)后疼痛及并發(fā)癥臨床觀察[J].吉林中醫(yī)藥,2013,33(8):805-807. PENG Y H,YANG W.Clinical efficacy of Zhitongan decoction for improving pain or accompanied symptoms after mixed hemorrhoid [J].Jilin Journal of Traditional Chinese Medicine,2013,33(8):805-807.
[14]程躍.高位肛瘺的手術(shù)治療進(jìn)展[J].臨床合理用藥雜志,2014,7(20):173-174. CHENG Y.Treatment progress in surgery for high complex anal fistula[J]. Chinese Journal of Clinical Rational Drug Use,2014,7(20):173-174.
[15]ALASARI S,KIM N K.Overview of anal fistula and systematic review of ligation of the intersphincteric fistula tract(LIFT)[J].Tech Coloproctol,2014,18(1):13-22.
[16]彭軍良,吳小妹,金玉弟,等.中藥促進(jìn)肛瘺術(shù)后創(chuàng)面愈合的進(jìn)展[J].中國(guó)中醫(yī)急癥,2013,22(6):962-964. PENG J L,WU X M,JIN Y D,et al.The progress of using traditional chinese medicine for wound healing after anal fistula surgery[J].Journal of Emergency in Traditional Chinese Medicine,2013,22(6):962-964.
[17]ZHAO L T,XIAO G S,QUAN Z C,et al.Experimental study on effects of moxibustion′s anti-inflammatory and immunity action on neurotransmitter[J].China Journal of Basic Medicine in Traditional Chinese Medicine,2000,6(9):53-55.
[18]TOYONAGA T,MATSUSHIMA M,SOGAWA N,et al.Postoperative urinary retention after surgery for benign anorectal disease:potential risk factors and strategy for prevention[J].Int J Colorectal Dis,2006,21(7):676-682.
[19]蕭華文,沈衛(wèi)東.電針八髎穴治療肛腸術(shù)后疼痛和術(shù)后恢復(fù)的療效觀察[J].四川中醫(yī),2015,33(3):159-161. XIAO H W,SHEN W D.Clinical efficacy of electroacupuncture at Baliao points for pain relief and postoperative rehabilitation after colorectal surgery [J].Journal of Sichuan of Traditional Medicine,2015,33(3):159-161.
[20]MATHIEU E,McGeechan K,Barratt A,et al.Internet-based randomized controlled trials:a systematic review[J].J Am Medical Inform Assoc,2013,20(3):568-576.
[21]LIU B,ZHOU X,WANG Y,et al.Data processing and analysis in real‐world traditional Chinese medicine clinical data:challenges and approaches[J].Stat Med,2012,31(7):653-660.
[22]FORTUNA D,NICOLINI F,GUASTAROBA P,et al.Coronary artery bypass grafting vs percutaneous coronary intervention in a ′real-world′setting:a comparative effectiveness study based on propensity score-matched cohorts[J].Eur J Cardiothorac Surg,2013,44(1):e16-24.
(本文編輯:崔莎)
Evaluation of the Clinical Effect of Sophora Flavescens Decoction Fumigation Combined with Box Moxibustion at Baliao Acupoint on Treating Postoperative Complications in Patients with High Complicated Anal Fistula on the Basis of Propensity Score Matching
CHENGYue*,ZHOUJin,HOUYan-mei,GUOYu-kun
TeachingHospitalofChengduUniversityofT.C.M,Chengdu610072,China
*Correspondingauthor:CHENGYue,Attendingphysician;E-mail:yuechengcdgc@126.com
Objective To evaluate the clinical effect of sophora flavescens decoction fumigation combined with box moxibustion at Baliao acupoint on treating postoperative complications in patients with high complicated anal fistula.Methods According to the inclusion criteria,873 high complicated anal fistula patients in Inpatient Department of Teaching Hospital of Chengdu University of T.C.M from September 2010 to September 2015 were retrospectively selected.By propensity score matching of SPSS 20.0,128 patients adopted sophora flavescens decoction fumigation combined with box moxibustion at Baliao acupoint(group A),128 used sophora flavescens decoction fumigation alone(group B) and 128 received box moxibustion at Baliao acupoint alone(group C).The patients in the three groups were treated for 14 days.The clinical effects of patients 14 days after operation were evaluated,the postoperative pain degree of patients at the first day,seven days and 14th after operation was evaluated by numeric rating scale(NRS) score,and incidence of urine retention of patients at the first day and the third day after operation was observed.Results At the 14th day after operation,the clinical efficacy of patients in the three groups was significantly different(P<0.05).The clinical effect in group A was better than that in group B and C(P<0.05),while there was no significant difference in the clinical effect between group B and C(P>0.05).The therapeutic method and treatment time had interactive effects on NRS score(P<0.05),the treatment time had no significant interactive effects on NRS score(P>0.05),while the therapeutic method had significant interactive effects on NRS score(P<0.05).The NRS score of patients at the 7th day after operation in group A was lower than that in group B and C(P<0.05);the NRS score of patients at the 7th day after operation in group B was lower than that in group C(P<0.05).The NRS score of patients at the 14th day after operation in group A and B was lower than that in group C(P<0.05),there was no significant difference in the NRS score of patients in group A and B at the 14th day after operation(P>0.05).The incidence of urine retention of patients in the three groups at the first day after operation was not significantly different(P>0.05).There was significant difference in the incidence of urine retention of patients in the three groups at the third day after operation(P<0.05).Conclusion Sophora flavescens decoction combined with box moxibustion at Baliao acupoint can effectively alleviate the postoperative pain and reduce the occurrence rate of urine retention of patients with high complicated anal fistula.
Rectal fistula;Sophora flavescens;Points,Baliao;Moxibustion;Treatment outcome
R 657.1
A
10.3969/j.issn.1007-9572.2017.03.015
2016-08-19;
2016-11-30)
610072四川省成都市,成都中醫(yī)藥大學(xué)附屬醫(yī)院
*通信作者:程躍,主治醫(yī)師;E-mail:yuechengcdgc@126.com